Vyant Bio, Inc. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported revenue was USD 0.165 million compared to USD 0.329 million a year ago. Net loss was USD 5.81 million compared to USD 4.19 million a year ago. Basic loss per share from continuing operations was USD 0.75 compared to USD 0.65 a year ago. Basic loss per share was USD 1 compared to USD 0.7 a year ago.
For the six months, revenue was USD 0.468 million compared to USD 0.532 million a year ago. Net loss was USD 14.97 million compared to USD 11.55 million a year ago. Basic loss per share from continuing operations was USD 1.5 compared to USD 3.5 a year ago. Basic loss per share was USD 2.55 compared to USD 3.6 a year ago.